Study of a Combination SARS-CoV-2 Recombinant Spike and High-Dose Inactivated Influenza Vaccine With Matrix-M Adjuvant in Adult Participants 60 Years of Age and Older

You may be eligible if

• Aged 60 years or older on the day of inclusion
• Informed consent form has been signed and dated
• Able to attend all scheduled visits and to comply with all study procedures
• Participant must be able to receive an injection in the deltoid muscle of both arms
• Participant must have completed a primary vaccination series against SARS-CoV-2 and at least 1 booster with a locally authorized or approved COVID-19 vaccine
• Aged 60 years or older on the day of inclusion
• Participants who are healthy or with pre-existing stable condition, as determined by medical evaluation including medical history and physical examination
• Non-childbearing potential (i.e., post-menopausal for at least 1 year or surgically sterile)
• Informed consent form has been signed and dated
• Able to attend all scheduled visits and to comply with all study procedures
• Participant must be able to receive an injection in the deltoid muscle of both arms
• Participant must have completed a primary vaccination series against SARS-CoV-2 and at least 1 booster with a locally authorized or approved COVID-19 vaccine
• The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.